310 related articles for article (PubMed ID: 30270490)
1. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
2. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
4. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
[TBL] [Abstract][Full Text] [Related]
5. Is multifocality a prognostic factor in childhood hepatoblastoma?
Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
[TBL] [Abstract][Full Text] [Related]
6. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
[TBL] [Abstract][Full Text] [Related]
7. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
8. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
[TBL] [Abstract][Full Text] [Related]
9. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
Czauderna P; Haeberle B; Hiyama E; Rangaswami A; Krailo M; Maibach R; Rinaldi E; Feng Y; Aronson D; Malogolowkin M; Yoshimura K; Leuschner I; Lopez-Terrada D; Hishiki T; Perilongo G; von Schweinitz D; Schmid I; Watanabe K; Derosa M; Meyers R
Eur J Cancer; 2016 Jan; 52():92-101. PubMed ID: 26655560
[TBL] [Abstract][Full Text] [Related]
10. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.
Dall'Igna P; Brugieres L; Christin AS; Maibach R; Casanova M; Alaggio R; de Goyet JV; Zsiros J; Morland B; Czauderna P; Childs M; Aronson DC; Branchereau S; Brock P; Perilongo G
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28921839
[TBL] [Abstract][Full Text] [Related]
11. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
[TBL] [Abstract][Full Text] [Related]
12. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Ueda Y; Kurihara S; Yano M; Hoshino K; Yokoi A; Takama Y; Nogami Y; Taguchi T; Mori M; Kihira K; Miyazaki O; Fuji H; Honda S; Iehara T; Kazama T; Fujimura J; Tanaka Y; Inoue T; Tajiri T; Kondo S; Oue T; Yoshimura K
J Clin Oncol; 2020 Aug; 38(22):2488-2498. PubMed ID: 32421442
[TBL] [Abstract][Full Text] [Related]
13. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
von Schweinitz D; Hecker H; Harms D; Bode U; Weinel P; Bürger D; Erttmann R; Mildenberger H
J Pediatr Surg; 1995 Jun; 30(6):845-52. PubMed ID: 7545228
[TBL] [Abstract][Full Text] [Related]
14. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
[TBL] [Abstract][Full Text] [Related]
15. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
[TBL] [Abstract][Full Text] [Related]
16. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
[TBL] [Abstract][Full Text] [Related]
18. Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.
Kim PH; Shin HJ; Yoon HM; Choi YH; Namgoong JM; Kim DY; Koh KN; Lee MJ; Yoon H; Lyu CJ; Han JW; Hahn SM; Cho YA
Cancer Res Treat; 2022 Jan; 54(1):253-258. PubMed ID: 33781052
[TBL] [Abstract][Full Text] [Related]
19. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
